Sunitinib with or without surgery for metastatic renal cell carcinoma

Comment: Kidney surgery may be unneeded in many intermediate-risk patients

Kidney surgery may be unneeded in many intermediate-risk patients

Editor’s Choice for May 2018

Thrombosis risk and management in multiple myeloma

Neoadjuvant nivolumab for resectable lung cancer

Response and safety profile of neoadjuvant nivolumab for resectable lung cancer

Management of marker negative stage II testicular cancer

Editor's Choice for February 2018

Comment: Urothelial cancer research from ASCO GU 2018

Guidelines and genomic factors for endometrial cancer

Options for breast reconstruction for younger breast cancer patients